155 related articles for article (PubMed ID: 1924336)
1. X-ray structure of trypanothione reductase from Crithidia fasciculata at 2.4-A resolution.
Kuriyan J; Kong XP; Krishna TS; Sweet RM; Murgolo NJ; Field H; Cerami A; Henderson GB
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8764-8. PubMed ID: 1924336
[TBL] [Abstract][Full Text] [Related]
2. Active site of trypanothione reductase. A target for rational drug design.
Hunter WN; Bailey S; Habash J; Harrop SJ; Helliwell JR; Aboagye-Kwarteng T; Smith K; Fairlamb AH
J Mol Biol; 1992 Sep; 227(1):322-33. PubMed ID: 1522596
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata.
Henderson GB; Fairlamb AH; Ulrich P; Cerami A
Biochemistry; 1987 Jun; 26(11):3023-7. PubMed ID: 3607007
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
5. The crystal structure of trypanothione reductase from the human pathogen Trypanosoma cruzi at 2.3 A resolution.
Zhang Y; Bond CS; Bailey S; Cunningham ML; Fairlamb AH; Hunter WN
Protein Sci; 1996 Jan; 5(1):52-61. PubMed ID: 8771196
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of parasite trypanothione reductase: acquisition of glutathione reductase activity in a triple mutant.
Sullivan FX; Sobolov SB; Bradley M; Walsh CT
Biochemistry; 1991 Mar; 30(11):2761-7. PubMed ID: 2007114
[TBL] [Abstract][Full Text] [Related]
7. Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution.
Bailey S; Smith K; Fairlamb AH; Hunter WN
Eur J Biochem; 1993 Apr; 213(1):67-75. PubMed ID: 8477734
[TBL] [Abstract][Full Text] [Related]
8. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
9. Engineering the substrate specificity of glutathione reductase toward that of trypanothione reduction.
Henderson GB; Murgolo NJ; Kuriyan J; Osapay K; Kominos D; Berry A; Scrutton NS; Hinchliffe NW; Perham RN; Cerami A
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8769-73. PubMed ID: 1924337
[TBL] [Abstract][Full Text] [Related]
10. The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state.
Lantwin CB; Schlichting I; Kabsch W; Pai EF; Krauth-Siegel RL
Proteins; 1994 Feb; 18(2):161-73. PubMed ID: 8159665
[TBL] [Abstract][Full Text] [Related]
11. Preliminary crystallographic analysis of trypanothione reductase from Crithidia fasciculata.
Kuriyan J; Wong L; Guenther BD; Murgolo NJ; Cerami A; Henderson GB
J Mol Biol; 1990 Oct; 215(3):335-7. PubMed ID: 2231707
[TBL] [Abstract][Full Text] [Related]
12. Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase.
Bradley M; Bücheler US; Walsh CT
Biochemistry; 1991 Jun; 30(25):6124-7. PubMed ID: 2059620
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the trypanothione reductase gene from Crithidia fasciculata and Trypanosoma brucei: comparison with other flavoprotein disulphide oxidoreductases with respect to substrate specificity and catalytic mechanism.
Aboagye-Kwarteng T; Smith K; Fairlamb AH
Mol Microbiol; 1992 Nov; 6(21):3089-99. PubMed ID: 1453951
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
Cunningham ML; Zvelebil MJ; Fairlamb AH
Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
[TBL] [Abstract][Full Text] [Related]
15. The glutamyl binding site of trypanothione reductase from Crithidia fasciculata: enzyme kinetic properties of gamma-glutamyl-modified substrate analogues.
el-Waer AF; Smith K; McKie JH; Benson T; Fairlamb AH; Douglas KT
Biochim Biophys Acta; 1993 Nov; 1203(1):93-8. PubMed ID: 8105896
[TBL] [Abstract][Full Text] [Related]
16. Initiating a crystallographic study of trypanothione reductase.
Hunter WN; Smith K; Derewenda Z; Harrop SJ; Habash J; Islam MS; Helliwell JR; Fairlamb AH
J Mol Biol; 1990 Nov; 216(2):235-7. PubMed ID: 2254926
[TBL] [Abstract][Full Text] [Related]
17. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
18. Structure of trypanothione reductase from Crithidia fasciculata at 2.6 A resolution; enzyme-NADP interactions at 2.8 A resolution.
Bailey S; Fairlamb AH; Hunter WN
Acta Crystallogr D Biol Crystallogr; 1994 Mar; 50(Pt 2):139-54. PubMed ID: 15299452
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases.
Shames SL; Fairlamb AH; Cerami A; Walsh CT
Biochemistry; 1986 Jun; 25(12):3519-26. PubMed ID: 3718941
[TBL] [Abstract][Full Text] [Related]
20. Molecular studies on trypanothione reductase: an antiparasitic target enzyme.
Walsh C; Bradley M; Nadeau K
Curr Top Cell Regul; 1992; 33():409-17. PubMed ID: 1354149
[No Abstract] [Full Text] [Related]
[Next] [New Search]
